Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Rheumatoid arthritis can rarely cause bilateral facial nerve palsy linked to p-ANCA positive vasculitis.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A man had two rare autoimmune diseases that might be connected.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Hair follicles and sweat glands show different keratin staining patterns.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Rituximab may cause skin issues, but baricitinib can help improve them.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Many children with alopecia areata also have other autoimmune diseases.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.